Reprogramming aging and the hidden sense of interoception

Life Biosciences has dosed its first volunteer with an experimental glaucoma treatment injected into the eye, aiming to regenerate healthy nerves. The company says that if the approach can reverse glaucoma, similar treatments might tackle other age-related diseases — and perhaps aging itself.

This strategy, which reprograms cells to a younger state, is gaining momentum among biotechs pursuing rejuvenation. Scientists use the term interoception for how we sense the body from the inside. Fueled by a 2021 Nobel Prize and new tools that map internal signaling, research is expanding as teams trace signals between body and brain.

A clearer picture is emerging with implications for conditions from obesity to chronic pain to anxiety, and some researchers call it a “new continent of awareness.” In broader tech news, SpaceX completed the largest IPO in history, raising $75 billion at a $1.77 trillion valuation and making Elon Musk the world’s first trillionaire on paper.

life biosciences, glaucoma, eye injection, nerve regeneration, cell reprogramming, rejuvenation, interoception, internal signaling, spacex, elon musk